• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

ZEG Berlin GmbH

Zentrum für Epidemiologie und Gesundheitsforschung

  • Home
  • Expertise
    • Real-World Evidence
    • Non-interventional study design
    • Post-authorization safety studies
    • Post-authorization efficacy studies
    • Cohort studies
    • Case-control studies
    • Medical Devices
    • Diagnostic tools
      • Research team
    • Data collection instruments
  • Services
    • RWE Services
    • Crisis Management
    • Consulting
    • Data Management and Biostatistics
    • Medical Writing
    • Study Management
    • Quality Assurance
    • Pharmacovigilance
  • Library & News
    • News/Conferences
    • Publications
  • About Us
    • Who We Are
      • Management Board
      • Executive Team
      • Project Management Team
    • History
    • Careers
    • Data Protection Information
  • Contact

Study Type: Methodology

Myon E, Martin N, Taïeb C, Heinemann Lothar A , Experiences with the French Aging Males' Symptoms (AMS) scale. Aging Male. 2005; 8(3/4):184-189.
Valenti G, Gontero P, Saccò M, Fontana F, Strollo F, Castellucci A, Heinemann Lothar A , Harmonized Italian version of the Aging Males' Symptoms scale. Aging Male. 2005; 8(3/4):180-183.
Kratzik C, Heinemann Lothar A , Saad F, Do Minh Thai, Rücklinger E, Composite screener for androgen deficiency related to the Aging Males’ Symptoms scale. Aging Male. 2005; 8 (3/4):157-161.
Heinemann Lothar A , Do Minh Thai, Assmann Anita, Schramm W, Schuermann R, Hilpert J, Spannagl M, VTE risk assessment – a prognostic model: BATER cohort study of young women Thrombosis Journal. 2005; 2005;3:5 (18 April 2005). DOI: 10.1186/1477-9560-3-5.
Heinemann Lothar A , Aging Males' Symptoms scale: a standardized instrument for the practice. J Endocrinol Invest. 2005; 28: 34-38.
Gontero P, Carboni F, Longoni C, Galzerano M, Parola A, Buffa B, Alberti E, Fontana F, Frea B, Aging male symptoms (AMS) scale scoring in a randomly screened male population of North Italy. J Sex Med. 2005; Suppl 1,P-048: 52.
Heinemann Lothar A , Potthoff P, Heinemann Klaas, Pauls Alfred, Ahlers C J, Saad F, Scale for Quality of Sexual Function (QSF) as an outcome measure for both genders?. J Sex Med. 2005; 2:82-95.
Moore C, Huebler D, Zimmermann T, Heinemann Lothar A , Saad F, Do Minh Thai, The AMS scale as outcome measure for treatment of androgen deficiency Eur Urology. 2004; 46:80-7.
Heinemann Klaas, Alexander Ruebig Alexander, Potthoff P, Schneider HPG, Strelow Frank, Heinemann Lothar A , Do Minh Thai, The Menopause Rating Scale: A methodological review. Health and Quality of Life Outcomes. 2004; 2:45 (2 September 2004). 10.1186/1477-7525-2-45.
Potthoff P, Heinemann Lothar A , A household panel as a tool for cost-effective health-related population surveys: validity of the “Healthcare Access Panel”. German Medical Science. 2004; 2:Doc05/20040716/.
Heinemann Lothar A , Do Minh Thai, Strelow Frank, Gerbsch Silvia, Schnitker Jörg, Schneider HPG, The Menopause Rating Scale (MRS) as outcome measure for hormone treatment? Health and Quality of Life Outcome. 2004; 2:67. Doi:10.1186/1477-7525-2-67.
Heinemann Lothar A , Recent results on HRT: Problems encountered by an epidemiologist. Menopause Review. 2004; 9:7-12.
  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to Next Page »

sidebar

Search our Publications

sidebar-alt

Footer

ZEG Berlin

Berlin Center for Epidemiology and Health Research

Invalidenstraße 115
10115 Berlin
Germany

Contact Us

Expertise

  • Real-World Evidence
  • Non-interventional study design
  • Post-authorization safety studies
  • Post-authorization efficacy studies
  • Cohort studies
  • Case-control studies
  • Medical Devices
  • Diagnostic tools
  • Data collection instruments

Services

  • Crisis Management
  • Consulting
  • Data Management and Biostatistics
  • Medical Writing
  • Study Management
  • Quality Assurance
  • Pharmacovigilance

ENCePP

We are a partner centre of the ENCePP scientific network which is coordinated by the European Medicines Agency. We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. We register studies in the ENCePP E-Register of Studies, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies.

General Data Protection Regulation

With a view to the introduction of the GDPR/EUDSGVO we are glad to present our newupdated privacy policy . The updated description are stored under “about us” and then “privacy policy/GDPR”. Further translation for study participants will follow contemporary.

© 2011–2023 ZEG Berlin

Impressum

Website by Laura Yeffeth.